Yentreve Europese Unie - Slowaaks - EMA (European Medicines Agency)

yentreve

eli lilly nederland b.v. - hydrochlorid duloxetínu - inkontinencia moču, stres - psychoanaleptics, - yentreve je indikovaný pre ženy na liečbu stredne ťažkej až ťažkej stresovej inkontinencie moču (sui).

Nodetrip (previously Xeristar) Europese Unie - Slowaaks - EMA (European Medicines Agency)

nodetrip (previously xeristar)

esteve pharmaceuticals, s.a. - duloxetine - anxiety disorders; depressive disorder, major; diabetic neuropathies - psychoanaleptics, - liečba depresívne poruchy;liečbe diabetickej periférne neuropatickej bolesti;spracovanie všeobecných úzkostnej poruchy;xeristar je indikovaný u dospelých.

Duloxetine Boehringer Ingelheim Europese Unie - Slowaaks - EMA (European Medicines Agency)

duloxetine boehringer ingelheim

boehringer ingelheim international gmbh - duloxetine - diabetické neuropatie - psychoanaleptics, - liečba diabetickej periférnej neuropatickej bolesti u dospelých.

Thymanax Europese Unie - Slowaaks - EMA (European Medicines Agency)

thymanax

servier (ireland) industries ltd - agomelatine - depresívna porucha, major - psychoanaleptics, - liečba veľkých depresívnych epizód u dospelých.

Valdoxan Europese Unie - Slowaaks - EMA (European Medicines Agency)

valdoxan

les laboratoires servier - agomelatine - depresívna porucha, major - psychoanaleptics, - liečba veľkých depresívnych epizód u dospelých.

Bendamustine Kabi 2,5 mg/ml Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bendamustine kabi 2,5 mg/ml

fresenius kabi s.r.o., Česká republika - bendamustín - 44 - cytostatica

Bendamustine Accord 2,5 mg/ml prášok na infúzny koncentrát Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bendamustine accord 2,5 mg/ml prášok na infúzny koncentrát

accord healthcare polska sp. z o.o., poľsko - bendamustín - 44 - cytostatica

Bendamustine Mylan 2,5 mg/ml Slowakije - Slowaaks - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bendamustine mylan 2,5 mg/ml

mylan s.a.s., francúzsko - bendamustín - 44 - cytostatica

Onivyde pegylated liposomal (previously known as Onivyde) Europese Unie - Slowaaks - EMA (European Medicines Agency)

onivyde pegylated liposomal (previously known as onivyde)

les laboratoires servier - irinotecan anhydrous free-base - pankreatické nádory - antineoplastické činidlá - liečba metastatického adenokarcinómu pankreasu, v kombinácii s 5 fluorouracil (5-fu) a leukovorínom (lv), u dospelých pacientov, ktorí postupovali po gemcitabínu založené terapia.

Celdoxome pegylated liposomal Europese Unie - Slowaaks - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - hydrochlorid doxorubicínu - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastické činidlá - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).